Compounding Lobby Calls FDA’s Marketing ‘Misleading’

Drug GMP Report

Mar. 04, 2014

The compounding pharmacy lobby is pushing back against the FDA’s campaign to encourage hospitals to buy compounded drugs only from agency-registered sites as disingenuous and misleading, saying the products aren’t necessarily safer for patients.
Read More